~ By Kumaran Pillai ~

Ireland's former state telecom operator eircom applied for court protection to allow it to restructure its 3.75 billion euro (US$5 billion) debt mountain. A move eircoms officials said was "necessary and unavoidable" (here).

The proposal allows the lenders to take control from the major shareholder Singapore Technologies Telemedia (STT), a subsidiary of Temasek Holdings. This is expected to cut the debt load by 40 to 50 percent.

Temasek Holdings bought 65% shareholdings of eircom for 140 million Euros in 2009. The other 35% was owned by their employee share trust.

In 2006, Temasek Holdings bought 49.6% stake in Shin Corporation, a leading Thai telecommunications company, through two nominees of Temasek Holdings (Cedar Holdings and Aspen Holdings). The investment was subsequently embroiled in controversy (here). There have been numerous reports of such failed investments in the past.

In a proposal by the Economic Strategies Committee in February 2010, the Government was encouraged to invest up to $1.5 billion in Singapore-based enterprises to help them grow and even take a stake in them (here). The proposal was, however, met with scepticism by our local bureaucrats.  

Huang Yasheng, the Beijing-born Massachusetts Institute of Technology (MIT) professor said that, ‘state-linked enterprise models are a sure-fire way to stifle the economy in the long run. The private sector is the best way to grow the economy. It has the most productive, most innovative and entrepreneurial culture. The state-owned enterprise system doesn't give you that.'

The fear is that despite all the foreign investment losses and evidence that state-owned enterprises don’t work, our administrators will continue with its current failed policy framework. 

_________________________

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

【冠状病毒19】首批莫德纳疫苗抵达狮城

由美国制药公司莫德纳研发的冠病疫苗,首批已在今日(17日)抵达狮城。负责运送疫苗的新航班机SQ7137,从比利时布鲁塞尔装载疫苗上机,并于今日下午1时40分,顺利抵达我国。 疫苗随即运往新翔集团的冷冻仓储中心Coolport储存。莫德纳也是我国批准使用的第二种疫苗。 卫生科学局本月初透过文告宣布,已批准美国药商modena莫德纳(Moderna)开发的冠病疫苗。 该疫苗的效能预计达94巴仙。与目前使用的辉瑞疫苗不同,莫德纳疫苗仅适合18岁及以上人群,两剂间相隔28天。 其副作用则与辉瑞疫苗相似,包括注射部位会疼痛、红肿、疲劳、头痛、肌肉疼痛、发烧、发冷、呕吐以及关节疼痛 卫生部表示,疫苗抵新后,会逐步为18岁及以上人群注射疫苗

Netizens on Josephine Teo’s remarks on having babies before flats

Questioned on whether young people are not getting their flats early enough…

Hong Kong's extradition Bill opponents storm into suburban Sha Tin district, Carrie Lam stays mum on total withdrawal

Protests against the Hong Kong government’s extradition Bill show no signs of…